On Sunday, January 11, 2026, senior leaders from across global biopharma will gather at the Jones Day office in San Francisco for the 2026 Global Biopharma Leadership Forum, co-hosted by MSQ Ventures and Jones Day. Supported by BioCentury Inc. The BayHelix Group, American Healthcare Executive Association, and KKH Advisors.

Building on eight successful Forums, this half-day program will bring together senior executives, investors, and innovators for strategic dialogue and high-level networking ahead of the JPM Healthcare Conference. Participants will exchange perspectives on global strategy, capital flows, and innovation models that shape the next wave of growth in biopharma.

The 2026 Forum program will highlight key questions for global biopharma leaders:

• Global Strategy & MNC Outlook: How leading pharma integrates regional innovation and partnership models 

• Investment & Deal-Making Trends: Cross-border capital flow, valuations, and 2025 transaction landscape 

• AI in Global Drug Development From target discovery to clinical execution — How AI is transforming speed and precision in biopharma 

• Roundtable & Closing Discussion – Defining a Winning Global Biotech Strategy for 2026+

The Forum will welcome:

• Senior executives from global and regional pharma and biotech companies

• Corporate development and business development leaders

• Investors and funds focused on healthcare and life sciences

• Entrepreneurs and innovators building global biopharma platforms 

If you are building, funding, or expanding a global biopharma business, we invite you to join us for focused insight, strategic discussion, and high-level networking with peers and partners.

---